Chronic Anticoagulation in Patients with Atrial Fibrillation and COVID-19: A Systematic Review and Meta-Analysis
I Landsteiner, JA Pinheiro, N Felix… - Arquivos Brasileiros …, 2024 - SciELO Brasil
Abstract Background: Coronavirus disease 2019 (COVID-19) is associated with
hypercoagulability. It remains uncertain whether ongoing anticoagulation for atrial fibrillation …
hypercoagulability. It remains uncertain whether ongoing anticoagulation for atrial fibrillation …
Incidence and Risk of Post-COVID-19 Thromboembolic Disease and the Impact of Aspirin Prescription; Nationwide Observational Cohort at the US Department of …
A Ware, ZP Veigulis, PJ Hoover, T Blumke, GN Ioannou… - medRxiv, 2024 - medrxiv.org
Introduction: COVID-19 triggers prothrombotic and proinflammatory changes, with
thrombotic disease prevalent in up to 30% SARS-CoV-2 infected patients. Early work …
thrombotic disease prevalent in up to 30% SARS-CoV-2 infected patients. Early work …
Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID pandemic
COI notes: Conflicts of Interest: DMS has received honoraria from BMS-Pfizer, Servier,
AstraZeneca, and Roche. GLG has received grants from Pfizer and Bristol-Myer Squibb, and …
AstraZeneca, and Roche. GLG has received grants from Pfizer and Bristol-Myer Squibb, and …
新型冠状病毒大规模感染期门诊患者常规血液检测指标血栓风险分析.
魏玲， 邵玲俐， 陈婷， 任娟… - China Tropical Medicine, 2023 - search.ebscohost.com
目的探究新型冠状病毒(severe acute respiratory syndrome coronavirus 2, SARS-CoV-2)
感染对轻型和普通型门诊患者的血栓风险影响. 方法以北京某三甲医院独立院区2022 …
感染对轻型和普通型门诊患者的血栓风险影响. 方法以北京某三甲医院独立院区2022 …
Higher Dose Anticoagulation Cannot Prevent Disease Progression in COVID-19 Patients: A Systematic Review and Meta-Analysis
Implementation of higher dose (HD) thromboprophylaxis has been considered in patients
infected with coronavirus disease 2019 (COVID-19). Our aim was to compare HD to …
infected with coronavirus disease 2019 (COVID-19). Our aim was to compare HD to …
[HTML][HTML] A Case Report of Disseminated Thromboses and Cardiac Ischemia in a Patient With COVID-19 Pneumonia
NA Guevara, L Rakovica, H Pleitez, MMF Chang… - Cureus, 2023 - ncbi.nlm.nih.gov
The novel coronavirus disease (COVID-19) pandemic caused by the SARS-CoV-2 virus
started in December 2019 in the city of Wuhan, in China's Hubei province. This virus quickly …
started in December 2019 in the city of Wuhan, in China's Hubei province. This virus quickly …
[HTML][HTML] Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19
F Khimani, AJ Wolf, B Yoon, A Blancke, C Gerhart… - Thrombosis …, 2023 - Elsevier
Thrombosis is a known complication of SARS-CoV-2 infection, particularly within a severely
symptomatic subset of patients with COVID-19 disease, in whom an aggressive host …
symptomatic subset of patients with COVID-19 disease, in whom an aggressive host …
Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies
M Porres-Aguilar, D Mukherjee, SC Didia… - …, 2024 - journals.sagepub.com
Novel coronavirus 2019 (COVID-19) represents a significant risk factor for the development
of venous thromboembolism (VTE) in hospitalized with both moderate and severe/critical …
of venous thromboembolism (VTE) in hospitalized with both moderate and severe/critical …
[HTML][HTML] Evaluation and Identification of Macrovascular Complications in Patients with COVID-19–Original Study
M Hassani, B Khanabadi, M Tavallaei… - Indian Journal of …, 2023 - journals.lww.com
Background: Coronavirus disease 2019 (COVID-19) is a pandemic that has affected many
patients worldwide. Infection with this virus appears to be associated with a high risk of …
patients worldwide. Infection with this virus appears to be associated with a high risk of …
Review of Post-discharge Thromboprophylaxis Practices and Outcomes in COVID-19 Patients
D Lor, A Meyers, L Hubbard, J Peterson, Y Lu - 2023 - preprints.org
Patients hospitalized with COVID-19 are at a higher risk of thrombotic events following
discharge, however the role of extended thromboprophylaxis remains controversial. The …
discharge, however the role of extended thromboprophylaxis remains controversial. The …